ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 887

$722K Total Retail Price of All Prescriptions

Rank: 15 out of 887

443 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

22% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 4,219 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 493 202 S3 1 1
LISINOPRIL 305 182 2 4
SIMVASTATIN 282 145 3 3
OMEPRAZOLE 230 76 4 2
LEVOTHYROXINE SODIUM 219 114 5 9
NEXIUM 209 86 6 18
HYDROCHLOROTHIAZIDE 204 124 7 10
METOPROLOL SUCCINATE 197 117 8 19
METFORMIN HCL 196 103 9 8
SPIRIVA 183 80 10 45
OXYCODONE HCL 182 28 S2 11 11
FUROSEMIDE 171 73 12 7
AZITHROMYCIN 158 83 13 34
CYMBALTA 153 19 14 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 87 15 22
AMLODIPINE BESYLATE 137 56 16 5
ZOLPIDEM TARTRATE 137 39 16 14
ATORVASTATIN CALCIUM 126 46 18 13
PREDNISONE 122 55 19 30
PROMETHAZINE HCL 121 28 R 20 69
TRAZODONE HCL 120 14 21 27
CRESTOR 118 17 22 25
CYCLOBENZAPRINE HCL 109 20 R 23 35
LYRICA 104 11 24 49
VENTOLIN HFA 100 18 25 89
FLUTICASONE PROPIONATE 96 22 26 29
METOPROLOL TARTRATE 93 49 27 16
TAMSULOSIN HCL 89 64 28 38
ALLOPURINOL 87 67 29 66
PRAVASTATIN SODIUM 85 50 30 12
CITALOPRAM HBR 85 41 30 23
GABAPENTIN 80 28 32 6
OXYCODONE HCL-ACETAMINOPHEN 78 15 S2 33 20
BYSTOLIC 72 34 34 148
SERTRALINE HCL 70 25 35 32
DEXILANT 69 33 36 116
POTASSIUM CHLORIDE 67 23 37 21
LOVASTATIN 67 28 37 58
FLUCONAZOLE 66 15 39 162
GLIPIZIDE 66 32 39 88
PROAIR HFA 65 15 41 39
ATENOLOL 59 28 42 37
TRAMADOL HCL 58 20 43 15
PAROXETINE HCL 58 40 43 91
FLUOXETINE HCL 58 0 43 62
MELOXICAM 57 22 46 28
MONTELUKAST SODIUM 56 0 47 169
AMOX TR-POTASSIUM CLAVULANATE 55 31 48 140
INSULIN SYRINGE 53 18 49 154
SYMBICORT 53 18 49 107
ADVAIR DISKUS 53 23 49 55
LANTUS 53 20 49 97
BENICAR HCT 51 37 53 338
IBUPROFEN 50 14 54 100
SINGULAIR 50 16 54 90
DIOVAN HCT 50 22 54 94
SYNTHROID 50 17 54 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.